PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
PALISADE BIO, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$1.34−0.07 (-4.96%)
Close on Oct 19, 2026
- Market cap
- $283.25M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Palisade Bio's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 10, 2026 | Aug 10, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2026 | Jun 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 12, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 29, 2026 | Apr 29, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2026 | Apr 2, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 20, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 3, 2025 | Dec 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 10, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 28, 2025 | Oct 28, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 21, 2025 | Oct 22, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 17, 2025 | Oct 20, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 15, 2025 | Oct 16, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 9, 2025 | Oct 9, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 26, 2025 | Sep 26, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 18, 2025 | Sep 18, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 15, 2025 | Sep 15, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 4, 2025 | Sep 5, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Aug 18, 2025 | Aug 18, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 23, 2025 | Jul 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 2, 2025 | Jul 9, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 29, 2025 | May 2, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2024 | Dec 16, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 27, 2024 | Sep 27, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 12, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 8, 2024 | Jul 8, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 22, 2024 | May 22, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 13, 2024 | SEC EDGAR |
| Current report | 8-K | May 10, 2024 | May 10, 2024 | SEC EDGAR |
| Current report | 8-K | May 3, 2024 | May 3, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 10, 2024 | Apr 10, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 5, 2024 | Apr 5, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2024 | Mar 27, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 26, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 6, 2024 | Mar 6, 2024 | SEC EDGAR |